Biblio Discovery — Demo Discovery Service

81 hasil untuk "Cihan Ay"

Menampilkan 1–20 · 0,30 detik · RSS

  1. Artikel Jurnal

    Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation

    Oliver Königsbrügge; Cihan Ay

    Research and Practice in Thrombosis and Haemostasis, Vol. 3 No. 4 · 2019 · Inggris · DOAJ Scopus

    Abstract Atrial fibrillation (AF) is a frequent comorbid condition in patients with end‐stage renal disease on hemodialysis (HD) with a prevalence of up to 27%. The incidence rate of stroke in AF patients on HD is approximately 5%. The AF‐associated risk of stroke is a major clinical challenge…

  2. Artikel Jurnal

    Clonal hematopoiesis and thrombosis risk—what are research and clinical gaps?

    Cornelia Englisch; Cihan Ay

    Research and Practice in Thrombosis and Haemostasis, Vol. 10 No. 4 · 2026 · Inggris · DOAJ Scopus

    Clonal hematopoiesis (CH) is characterized by the clonal expansion of hematopoietic stem cells driven by somatic mutations that confer a survival or proliferative advantage. In recent years, numerous studies have identified an association between clonal hematopoiesis and adverse cardiovascular…

  3. Artikel Jurnal Teks lengkap

    Biological Aging and Venous Thromboembolism: A Review of Telomeres and Beyond

    Rafaela Vostatek; Cihan Ay

    Biomedicines, Vol. 13 No. 1 · 2024 · Inggris · DOAJ Scopus

    Although venous thromboembolism (VTE) is the third most common cardiovascular disease, and the risk of VTE increases sharply with advancing age, approximately 40% of VTE cases are currently classified as unprovoked, highlighting the importance of risk factor research. While chronological aging is…

  4. Artikel Jurnal

    Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence

    Stephan Nopp; Daniel Kraemmer; Cihan Ay

    Frontiers in Cardiovascular Medicine, Vol. 9 · 2022 · Inggris · DOAJ Scopus

    Although anticoagulation therapy has evolved from non-specific drugs (i.e., heparins and vitamin K antagonists) to agents that directly target specific coagulation factors (i.e., direct oral anticoagulants, argatroban, fondaparinux), thrombosis remains a leading cause of death worldwide. Direct…

  5. Artikel Jurnal

    Risk assessment for recurrent venous thromboembolism in patients with cancer

    Cornelia Englisch; Florian Moik; Cihan Ay

    Thrombosis Update, Vol. 5 · 2021 · Inggris · DOAJ Scopus

    Cancer patients are at high risk for first and recurrent venous thromboembolism (VTE). While various risk factors for a first cancer-associated VTE event have been identified, information on risk factors for recurrent VTE is limited or inconsistent. Therefore, risk assessment for VTE recurrence in…

  6. Artikel Jurnal

    Risk assessment models of cancer-associated thrombosis - Potentials and perspectives

    Florian Moik; Cornelia Englisch; Ingrid Pabinger dkk.

    Thrombosis Update, Vol. 5 · 2021 · Inggris · DOAJ Scopus

    Patients with cancer are at increased risk of venous thromboembolism (VTE). Risk assessment models can help identifying high-risk populations that might benefit from primary thromboprophylaxis. Currently, the Khorana score is suggested to select patients for primary thromboprophylaxis. However…

  7. Artikel Jurnal

    Fibrinolysis and bleeding of unknown cause

    Dino Mehic; Ingrid Pabinger; Cihan Ay dkk.

    Research and Practice in Thrombosis and Haemostasis, Vol. 5 No. 4 · 2021 · Inggris · DOAJ Scopus

    Abstract Patients with bleeding of unknown cause (BUC) present with a variety of mild to moderate bleeding symptoms, but no hemostatic abnormalities can be found. Hyperfibrinolysis is rarely evaluated as the underlying cause for bleeding in clinical practice, and well‐established global assays for…

  8. Artikel Jurnal

    Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies

    Nikola Vladic; Cornelia Englisch; Cihan Ay dkk.

    Research and Practice in Thrombosis and Haemostasis, Vol. 9 No. 1 · 2025 · Inggris · DOAJ Scopus

    Venous thromboembolism remains a major cause of morbidity and mortality among ambulatory cancer patients, necessitating effective risk assessment and prevention strategies. Despite the availability of risk assessment models and guidelines recommending primary thromboprophylaxis with…

  9. Artikel Jurnal

    Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis

    Stephan Nopp; Florian Moik; Bernd Jilma dkk.

    Research and Practice in Thrombosis and Haemostasis, Vol. 4 No. 7 · 2020 · Inggris · DOAJ Scopus

    Abstract Background Venous thromboembolism (VTE) is frequently observed in patients with coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially. Objectives We aimed at evaluating available data and estimating the prevalence of VTE in patients with COVID‐19. Methods We…

  10. Artikel Jurnal

    Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials

    Florian Moik; Florian Posch; Christoph Zielinski dkk.

    Research and Practice in Thrombosis and Haemostasis, Vol. 4 No. 4 · 2020 · Inggris · DOAJ Scopus

    Abstract Background Low‐molecular‐weight‐heparins (LMWHs) have been established for the treatment of cancer‐associated venous thromboembolism (VTE). Recently published randomized controlled trials (RCTs) have compared direct oral anticoagulants (DOACs) with LMWHs. The aim of this systematic review…

  11. Artikel Jurnal

    A Systematic Review of Safety and Efficacy of Factor XI/XIa Inhibitors in Patients With ESKD on Hemodialysis

    Daniel Steiner; Daniel Kraemmer; Stephan Nopp dkk.

    Kidney International Reports, Vol. 10 No. 1 · 2025 · Inggris · DOAJ Scopus

    Introduction: Factor XI/XIa (FXI/XIa) has emerged as a potential target for antithrombotic therapy, driven by preclinical evidence showing the role of FXI/XIa inhibition for preventing thrombosis without impeding hemostasis. This is particularly promising for patients at high risk of both…

  12. Artikel Jurnal

    Impaired glucose metabolism is associated with increased thrombin generation potential in patients undergoing angioplasty and stenting

    Silvia Lee; Cihan Ay; Christoph W. Kopp dkk.

    Cardiovascular Diabetology, Vol. 17 No. 1 · 2018 · Inggris · DOAJ Scopus

    Abstract Background As a strong platelet agonist on the one hand and key molecule in plasmatic coagulation on the other hand, thrombin connects primary and secondary hemostasis. Thrombin generation potential reflects the individual capacity to generate thrombin, and has been associated with the…

  13. Artikel Jurnal

    Association of air pollution and atmospheric conditions on pulmonary embolism incidence and severity

    Stephan Nopp; Julia Bohnert; Thomas Mayr dkk.

    Research and Practice in Thrombosis and Haemostasis, Vol. 10 No. 2 · 2026 · Inggris · DOAJ Scopus

    Background: Pulmonary embolism (PE) is a major cause of morbidity and mortality. In addition to traditional risk factors, environmental exposures such as air pollution and atmospheric conditions may influence PE risk, although existing evidence is inconsistent. Objectives: We aimed to investigate…

  14. Artikel Jurnal Teks lengkap

    Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of Life

    Stephan Nopp; Florian Moik; Frederikus Albertus Klok dkk.

    Respiration · 2022 · Inggris · OpenAlex Scopus

    BACKGROUND: COVID-19 survivors face the risk of long-term sequelae including fatigue, breathlessness, and functional limitations. Pulmonary rehabilitation has been recommended, although formal studies quantifying the effect of rehabilitation in COVID-19 patients are lacking. METHODS: We conducted a…

  15. Artikel Jurnal Teks lengkap

    Red Cell Distribution Width and Other Red Blood Cell Parameters in Patients with Cancer: Association with Risk of Venous Thromboembolism and Mortality

    Julia Riedl; Florian Posch; Oliver Königsbrügge dkk.

    PLoS ONE, Vol. 9 No. 10 · 2014 · Inggris · PLOS Scopus

    Background: Cancer patients are at high risk of developing venous thromboembolism (VTE). Red cell distribution width (RDW) has been reported to be associated with arterial and venous thrombosis and mortality in several diseases. Here, we analyzed the association between RDW and other red blood cell…

  16. Artikel Jurnal

    Bleeding outcomes and factor utilization after switching to an extended half-life product for prophylaxis in haemophilia A in Austria

    Cihan Ay; Clemens Feistritzer; Joachim Rettl dkk.

    Scientific Reports, Vol. 11 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract To prevent bleeding in severe haemophilia A [SHA, defined as factor VIII (FVIII) activity

  17. Artikel Jurnal

    Impaired thrombin generation as a reproducible feature of bleeding disorder of unknown cause

    Tim Dreier; Dino Mehic; Justin Oosterlee dkk.

    Research and Practice in Thrombosis and Haemostasis, Vol. 10 No. 3 · 2026 · Inggris · DOAJ Scopus

    Background: Thrombin generation (TG) has previously been investigated in patients with bleeding disorder of unknown cause (BDUC) with discrepant results. Objective: To investigate whether previously reported impairments of TG in BDUC patients can be resproduced using a automated TG analysed at…